Omnicell (OMCL) Capital Expenditures (2016 - 2026)
Omnicell has reported Capital Expenditures over the past 16 years, most recently at $39.9 million for Q4 2025.
- Quarterly Capital Expenditures rose 10.75% to $39.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $40.4 million through Dec 2025, up 10.84% year-over-year, with the annual reading at $40.4 million for FY2025, 10.84% up from the prior year.
- Capital Expenditures was $39.9 million for Q4 2025 at Omnicell, up from -$182000.0 in the prior quarter.
- Over five years, Capital Expenditures peaked at $39.9 million in Q4 2025 and troughed at -$19.6 million in Q3 2022.
- The 5-year median for Capital Expenditures is $3.9 million (2021), against an average of $6.0 million.
- The largest YoY upside for Capital Expenditures was 2259.14% in 2022 against a maximum downside of 387.56% in 2022.
- A 5-year view of Capital Expenditures shows it stood at -$17.0 million in 2021, then surged by 96.58% to -$581000.0 in 2022, then surged by 1661.1% to $9.1 million in 2023, then skyrocketed by 297.25% to $36.0 million in 2024, then grew by 10.75% to $39.9 million in 2025.
- Per Business Quant, the three most recent readings for OMCL's Capital Expenditures are $39.9 million (Q4 2025), -$182000.0 (Q3 2025), and -$284000.0 (Q2 2025).